Your browser doesn't support javascript.
loading
A costing analysis of B-GAP: index-linked HIV testing for children and adolescents in Zimbabwe.
Vasantharoopan, Arthi; Maheswaran, Hendramoorthy; Simms, Victoria; Dziva Chikwari, Chido; Chigwenah, Tariro; Chikodzore, Rudo; Nyathi, Khulamuzi; Ncube, Gertrude; Ferrand, Rashida A; Guinness, Lorna.
Afiliação
  • Vasantharoopan A; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. arthi.vasantharoopan@lshtm.ac.uk.
  • Maheswaran H; Institute for Global Health Innovation, Imperial College London, London, UK.
  • Simms V; MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.
  • Dziva Chikwari C; Biomedical Research and Training Institute, Harare, Zimbabwe.
  • Chigwenah T; Biomedical Research and Training Institute, Harare, Zimbabwe.
  • Chikodzore R; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, UK.
  • Nyathi K; Health Economics Unit, University of Cape Town, Cape Town, South Africa.
  • Ncube G; Matebeleland South, Ministry of Health and Child Care, Bulawayo, Zimbabwe.
  • Ferrand RA; City Health Department, Bulawayo City Council, Bulawayo, Zimbabwe.
  • Guinness L; Ministry of Health and Child Care, Harare, Zimbabwe.
BMC Health Serv Res ; 21(1): 1082, 2021 Oct 12.
Article em En | MEDLINE | ID: mdl-34641871
ABSTRACT

BACKGROUND:

By testing children and adolescents of HIV positive caretakers, index-linked HIV testing, a targeted HIV testing strategy, has the ability to identify high risk children and adolescents earlier and more efficiently, compared to blanket testing. We evaluated the incremental cost of integrating index-linked HIV testing via three modalities into HIV services in Zimbabwe.

METHODS:

A mixture of bottom-up and top-down costing was employed to estimate the provider cost per test and per HIV diagnosis for 2-18 year olds, through standard of care testing, and the incremental cost of index-linked HIV testing via three modalities facility-based testing, home-based testing by a healthcare worker, and testing at home by the caregiver using an oral mucosal transudate test. In addition to interviews, direct observation and study process data, facility registries were abstracted to extract outcome data and resource use. Costs were converted to 2019 constant US$.

RESULTS:

The average cost per standard of care test in urban facilities was US$5.91 and US$7.15 at the rural facility. Incremental cost of an index-linked HIV test was driven by the uptake and number of participants tested. The lowest cost approach in the urban setting was home-based testing (US$6.69) and facility-based testing at the rural clinic (US$5.36). Testing by caregivers was almost always the most expensive option (rural US$62.49, urban US$17.49).

CONCLUSIONS:

This is the first costing analysis of index-linked HIV testing strategies. Unit costs varied across sites and with uptake. When scaling up, alternative testing solutions that increase efficiency such as index-linked HIV testing of the entire household, as opposed to solely targeting children/adolescents, need to be explored.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Teste de HIV Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Teste de HIV Idioma: En Ano de publicação: 2021 Tipo de documento: Article